|
Resolution: standard / high Figure 6.
Structures of the two A3AR-selective agonists used in the study. (a) IB-MECA is a 9-riboside derivative, a structural feature shared with native adenosine.
(b) The more potent and selective agonist MRS3558 contains a modified methanocarba ring
system in place of ribose. The methanocarba substitution consists of fused cyclopentane
and cyclopropane rings, which serve to constrain this moiety in a conformation that
is preferred in the A3AR binding site. Both analogs share the N6-benzyl-type substitution, which is particularly
suited for high affinity at the A3AR in various species. The methylamide moiety attached at the 4'-position serves to
increase A3AR affinity and to maintain full efficacy in A3AR activation. The 2-chloro substitution of MRS3558 enhances A3AR affinity and selectivity. AR, adenosine receptor.
Matot et al. Critical Care 2006 10:R65 doi:10.1186/cc4893 |